Investment
Features
FeesSafety
Academy
More
Pluang+

Compare UiPath Inc (PATH) vs Raytheon Technologies Corp (RTX) Price & Performance

UiPath IncTrade
Raytheon Technologies CorpTrade

Price performance (Past 24H)

Key statistics

UiPath Inc vs Raytheon Technologies Corp — how do they compare? UiPath Inc trades at $13.48 (market cap $6.91B), while Raytheon Technologies Corp trades at $185.97 (market cap $248.42B). The key difference: Raytheon Technologies Corp is far larger — about 36× UiPath Inc's market cap, and Raytheon Technologies Corp pays a 1.58% dividend while UiPath Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold UiPath Inc for 139 Days and Raytheon Technologies Corp for 77 Days on average.

PATHRTX
Market Cap
$6.91B$248.42B
Volume
34,321,2504,380,368
Sector
TechnologyIndustrials
52-Week High
$19.29$225.49
52-Week Low
$9.38$157.00
Typical Hold Time
139 Days77 Days
Enterprise Value
$5.70B$278.97B
Dividend Yield
—1.58%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

UiPath Inc

UiPath (PATH) trades at $13.25, up 1.38% today, with a bullish technical signal from moving averages despite neutral oscillators. The company shows improving fundamentals with revenue growing from $1.43B in 2025 to projected $1.7B in 2026, while narrowing net losses from -$74M to projected $362M profit. Recent partnerships with Snowflake and BDO highlight strategic expansion in AI orchestration capabilities.

PATH offers compelling value at current levels with 14% upside to consensus price target of $15.13. Strong enterprise AI adoption and improved profitability outlook support growth, though execution risks and competitive pressures in automation software warrant monitoring. The stock presents a balanced risk-reward profile for investors seeking automation exposure.

Raytheon Technologies Corp

RTX trades at $184.32, up 2.25% with strong earnings momentum as Q1 and Q2 2026 results beat expectations. The stock shows bearish technical signals but benefits from a $289 billion backlog and rising defense spending. Revenue grew to $88.6 billion in 2025 with net income of $6.73 billion, while analyst consensus remains bullish with a $236.27 price target.

Outlook is positive given defense budget tailwinds and operational execution, though technical weakness and debt levels pose risks. The company's dividend and backlog provide stability, but investors should monitor geopolitical impacts and interest rate sensitivity.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

PATH
1% Buy99% Sell
Avg holding period · 139 Days
RTX
94% Buy6% Sell
Avg holding period · 77 Days

Top news

Latest headlines on both assets

About UiPath Inc

UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, and professional services. It generates a majority of the revenues from the US, followed by Romania and the rest of the world.

Read more on PATH →

About Raytheon Technologies Corp

Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.

Read more on RTX →